talent-profile-avatar

Michael

M&A, Investment, Fundraising

Amsterdam, Netherlands

Strategy&, Part Of The PwC Network (formerly Booz & Company) PwC PricewaterhouseCoopers Oliver Wyman Consulting

Leveraging extensive project experience across M&A, strategy consulting, and investing, I excel in managing transaction processes, crafting effective strategic narratives, and assessing investment opportunities. I am dedicated to guiding entrepreneurs and investors to successful transactions. I provide tailored services including: - Sell-side M&A advisor for SMEs - Commercial due diligence for PE/VC - Fundraising advisor for startups/scale-ups Specialization: Venture Capital; Fundraising; Private Equity; M&A; Commercial Due Diligence; Deal Valuation

Domain experience

Relevant Total Experience: 8 years

Seniority Level: Senior

Sector Experience: 

Banks Diversified Financials Household Durables Insurance Pharmaceuticals, Biotechnology and Life Sciences Software and Services

Skills

Skilled in: Corporate Strategy, Divestitures, Venture and minority investments, Commercial Due Diligence, Vendor Due Diligence, Term Sheet, Bolt-on acquisitions, Buy-and-Build, Value Creation & Enhancement, Private Equity & Growth Capital, Sell-side M&A, Corporate Development, Buy-Side M&A

Technical Skills: Microsoft Excel, PowerPoint, Microsoft Office, Capital IQ, Python

Languages: English, Chinese (Mandarin)

Work Experience

Surmount Ventures

Investment Manager

01/03/2021

 

- 1/3/2024

- Directed the sell-side execution of a platform investment (encompassing 4x biotech portfolio companies), securing 4x LOIs from mid-to-large cap private equity investors. Key responsibilities included exit readiness preparation, equity story and Information Memorandum, drafting Q&A replies, management session coordination, and deal structure / fund flow evaluation - Conducted initial evaluation, led pitch sessions of all opportunities of the venture / growth fund in Health & Technology - Synthesized IC memorandums; performed commercial & financial due diligence and managed legal & IP DD advisors - Defined transaction structures and managed legal closing processes in Dutch, UK, and US jurisdictions - Closed 3x investments at Seed and Series A stages in Biotech and Deeptech - Initiated and spearheaded the investment thesis development of early-stage investments in AI and TechBio / Digital Health

HHV Biotech

Venture Builder - Corporate Development

1/3/2021

 

- 1/2/2022

- Launched Surmount’s venture studio infectious diseases biotech company, as a core member of the two-person founding team, and grew the company from a research concept with a lead compound to a preclinical stage entity within the first year - Identified and prioritized top-3 medical indications based on market, clinical development, and route of administration - Collaborated with expert advisors on mapping out the full preclinical drug development plan - Developed a scenario-based financial planning / cash flow model based on a series of go / no-go decision points - Interviewed panels of key opinion leaders and initiated academic partnerships - Selected CROs / CDMOs and coordinated interdependent development activities across multiple external research sites

Strategy&, part of the PwC network

Manager - M&A Deals

01/10/2020

 

- 01/02/2021

- Led 20+ commercial due diligence and validated all strategic aspects of private equity investments, including market size / segmentation, competitive position, value chain, synergy potential, business plan achievability and value creation levers - Formulated growth / market entry strategies alongside private equity portfolio companies’ C-level executive teams - Developed equity stories and IM for mid-market deals with a focus on financial services and technology - Mapped the Benelux Fintech landscape and advised financial institutions to develop their Fintech investment strategies

Strategy&, part of the PwC network

Senior Associate - M&A Deals

01/09/2018

 

- 01/09/2020

- Corporate finance: Buy side and sell side deal origination and execution with a focus on cross-border mid-market transactions - Valuation: Financial modeling using various methods, including DCF, LBO, Multiples, with a focus on financial services - Commercial due diligence: Market sizing, expert interviews, and business plan assessments - Financial due diligence: Quality of earnings, EV to equity bridge (net debt, net working capital)

PwC

M&A Deals Associate

01/09/2016

 

- 01/08/2018

Oliver Wyman

Summer Management Consultant

01/06/2015

 

- 01/08/2015

- Managed the PMO for the Asset Liability Management division of a top-3 Dutch bank as part of the bank’s broader IPO process

Berkeley SkyDeck

Financial Planning Intern

01/11/2014

 

- 01/01/2015

- Built a five-year financial plan for an Automated Speech Recognition startup – Remeeting

Education

CFA Institute

Investment Management

01/12/2017

 

- 01/06/2019

- Charterholder since 06/2020 and passed all three levels above the 90th percentile worldwide on the first attempt

Rotterdam School of Management, Erasmus University

Finance and Investments

01/09/2015

 

- 01/07/2016

- GPA: 4.0/4.0; GMAT: 740/800; NL Grade: 8.5/10/0 - Full scholarship; Cum Laude; Honors Program - Top 2% in courses including corporate finance, investments, and advanced valuation - Organizer of the International Business Project (Tel Aviv); Rotterdam Consulting Club

Haas School of Business, University of California, Berkeley

Business Administration

01/08/2014

 

- 01/12/2014

- GPA: 3.9/4.0

Utrecht University

Economics and Business Economics

01/09/2012

 

- 01/07/2015

- GPA: 4.0/4.0; NL Grade: 8.9/10.0 - Ranked No. 1 among a cohort of more than 300 students; Cum Laude; Honors Program - Investment Committee

Licenses / Certificates

CFA Institute

Chartered Financial Analyst (CFA)

30/08/2021

 

Stanford University

Machine Learning Specialization

Want to work with Michael?

Sign up on the Fintalent platform to get in touch with Michael and 2,500+ other M&A freelancers!